Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: February 14, 2023
Reporting Period: The filing announces financial results for the three months ended December 31, 2023. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
This Form 8-K serves as a notification of the issuance of a press release regarding financial results. The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained in the referenced press release (Exhibit 99.1), which is not included in the provided source text.
Material Changes
The filing does not provide specific data to compare current period performance against prior comparable periods. It only confirms the announcement of results for the three months ended December 31, 2023.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on February 14, 2023, detailing the financial results.
Legal Disclaimer: The information in this report and its exhibits is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Guidance/Risks: No specific guidance, outlook, or risk factors are detailed within the body of this 8-K filing.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) by reviewing the full text of the Press Release dated February 14, 2023 (Exhibit 99.1).
- Confirm the accuracy of the reporting period, as the filing text states results for the three months ended December 31, 2023, while the filing date is February 2023.
- Review the Company's status as an emerging growth company for potential differences in financial reporting standards.
- Check subsequent filings for any updates or corrections to the initial press release data.